Eli Lilly and Company (NYSE:LLY) Receives “Buy” Rating from Guggenheim
Guggenheim restated their buy rating on shares of Eli Lilly and Company (NYSE:LLY – Free Report) in a report released on Friday morning,Benzinga reports. Guggenheim currently has a $936.00 target price on the stock. LLY has been the subject of several other reports. Wells Fargo & Company reiterated an “overweight” rating on shares of Eli […]
Guggenheim restated their buy rating on shares of Eli Lilly and Company (NYSE:LLY – Free Report) in a report released on Friday morning,Benzinga reports. Guggenheim currently has a $936.00 target price on the stock. LLY has been the subject of several other reports. Wells Fargo & Company reiterated an “overweight” rating on shares of Eli […]
